✦ LIBER ✦

A randomized study of methotrexate, bleomycin, hydroxyurea with versus without cisplatin in patients with previously untreated and recurrent squamous cell carcinoma of the head and neck

✍ Scribed by Abele, R.; Honegger, H.P.; Grossenbacher, R.; Mermillod, B.; Kaplan, E.; Gervasi, A.; Wolfensberger, M.; Lehmann, W.; Cavalli, F.

Book ID: 123241925
Publisher: Elsevier Science
Year: 1987
Weight: 634 KB
Volume: 23
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(87)90418-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy with methotrexa

Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck

✍ M. Clavel; F. Cognetti; P. Dodion; J. Wildiers; R. Rosso; A. Rossi; B. Gignoux; 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 2 views

## For the EORTC Head and Neck Cooperative Group A total of 185 eligible patients with advanced inoperable squamous cell carcinoma of the head and neck were randomized into two groups; the cisplatin, methotrexate, bleomycin, and vincristine (CABO) group received cisplatin (50 mg/m2; day 4), methot

A prospective randomized trial of methot

A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neck

✍ Waun Ki Hong; Steven Schaefer; Brian Issell; Charles Cummings; Daniel Luedke; Ri 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB

Induction chemotherapy with cisplatinum,

Induction chemotherapy with cisplatinum, 5-fluorouracil, bleomycin, mitomycin C and hydroxyurea for previously untreated locally advanced squamous cell carcinomas of the head and neck

✍ G. Fountzilas; A. Nicolaou; K. Sridhar; T. Sideras; A. Haritanti; C. Anastasakis 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 469 KB

Combination chemotherapy with cisplatin,

Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neck

✍ Marcel Rozencweig; Pierre Dodion; Uta Bruntsch; Walter Gallmeier; Michel Clavel; 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

A combination of cisplatin, methotrexate, bleomycin, and vincristine (CABO) was assessed in advanced epidermoid head and neck cancer. Among 72 patients with recurrent or metastatic disease and measurable lesions, there were 9 complete and 27 partial responses for an overall response rate of 50%. The

A randomized phase III study of cisplati

A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California oncology group study

✍ Charlotte Jacobs; Frederick Meyers; Charles Hendrickson; Marsha Kohler; Steve Ca 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB

Randomized comparison ofcis-diamminedich

Randomized comparison ofcis-diamminedichloroplatinum versuscis-diamminedichloroplatinum, methotrexate, and bleomycin in recurrent squamous cell carcinoma of the head and neck

✍ S. Davis; W. Kessler 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 259 KB